ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OTLK Outlook Therapeutics Inc

7.85
-0.05 (-0.63%)
May 28 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -18.92M-17.04M-14M-15.67M-6.86M-18.15M-12.47M-10.32M
Pre Tax Income -19.7M-17.54M-14.34M-18.66M-6.65M-20.68M-12.99M-11.18M
Net Income -19.7M-17.54M-14.35M-18.66M-6.65M-20.68M-12.99M-11.18M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -18.92M-17.92M-14M-15.67M-6.86M-21.06M-13.31M-11.31M
EBITDA -18.87M-16.97M-13.98M-15.66M-6.84M-18.14M-12.46M-10.29M
Year End September 29 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.98M3.81M3.09M8.15M0000
Operating Income -51.76M-35.88M-29.64M-36.3M-36.84M-51.77M-63.12M-53.14M
Pre Tax Income -53.23M-38.35M-33.74M-37.94M-38.51M-53.16M-66.05M-58.98M
Net Income -63.17M-40.03M-48.02M-36.04M-48.87M-53.16M-66.05M-58.98M
Preferred Dividends 000-625k-10.5M000
Basic Earnings Per Share (EPS) -2.77-1.605-0.665-1.26-0.384-0.301-0.291-0.227
EBIT -51.76M-35.88M-30.9M-36.91M-36.94M-51.77M-64M-56.89M
EBITDA -49.36M-33.19M-26.59M-21.67M-36.09M-51.61M-62.96M-53.09M